ARCT
Price
$13.33
Change
-$1.08 (-7.49%)
Updated
Jun 27 closing price
Capitalization
361.25M
43 days until earnings call
CVAC
Price
$5.38
Change
-$0.02 (-0.37%)
Updated
Jun 27 closing price
Capitalization
1.21B
46 days until earnings call
Interact to see
Advertisement

ARCT vs CVAC

Header iconARCT vs CVAC Comparison
Open Charts ARCT vs CVACBanner chart's image
Arcturus Therapeutics Holdings
Price$13.33
Change-$1.08 (-7.49%)
Volume$1.2M
Capitalization361.25M
CureVac
Price$5.38
Change-$0.02 (-0.37%)
Volume$770.68K
Capitalization1.21B
ARCT vs CVAC Comparison Chart in %
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. CVAC commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Buy and CVAC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ARCT: $13.33 vs. CVAC: $5.40)
Brand notoriety: ARCT and CVAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 266% vs. CVAC: 0%
Market capitalization -- ARCT: $361.52M vs. CVAC: $1.21B
ARCT [@Biotechnology] is valued at $361.52M. CVAC’s [@Biotechnology] market capitalization is $1.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileCVAC’s FA Score has 1 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • CVAC’s FA Score: 1 green, 4 red.
According to our system of comparison, CVAC is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 4 TA indicator(s) are bullish while CVAC’s TA Score has 1 bullish TA indicator(s).

  • ARCT’s TA Score: 4 bullish, 3 bearish.
  • CVAC’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, ARCT is a better buy in the short-term than CVAC.

Price Growth

ARCT (@Biotechnology) experienced а +8.46% price change this week, while CVAC (@Biotechnology) price change was -0.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ARCT is expected to report earnings on Aug 11, 2025.

CVAC is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVAC($1.21B) has a higher market cap than ARCT($361M). CVAC YTD gains are higher at: 57.771 vs. ARCT (-21.450). CVAC has higher annual earnings (EBITDA): 228M vs. ARCT (-63.92M). CVAC has more cash in the bank: 442M vs. ARCT (217M). CVAC has less debt than ARCT: CVAC (37.4M) vs ARCT (42.7M). CVAC has higher revenues than ARCT: CVAC (524M) vs ARCT (131M).
ARCTCVACARCT / CVAC
Capitalization361M1.21B30%
EBITDA-63.92M228M-28%
Gain YTD-21.45057.771-37%
P/E RatioN/A5.77-
Revenue131M524M25%
Total Cash217M442M49%
Total Debt42.7M37.4M114%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTCVAC
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZTSTF0.230.03
+15.00%
ZTEST Electronics, Inc.
MGAAF15.51N/A
N/A
Morinaga & Co., Ltd.
FRCOF315.00N/A
N/A
Fast Retailing Co. Ltd.
NZEOF0.20N/A
N/A
ECHELON RES LTD.
RXLSF28.32N/A
N/A
Rexel SA

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with TRDA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
-7.49%
TRDA - ARCT
53%
Loosely correlated
-1.57%
RGNX - ARCT
52%
Loosely correlated
-4.11%
ABCL - ARCT
51%
Loosely correlated
-3.48%
MRNA - ARCT
50%
Loosely correlated
-1.38%
RXRX - ARCT
49%
Loosely correlated
-6.85%
More

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with AIM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
-0.37%
AIM - CVAC
43%
Loosely correlated
-7.04%
MRNA - CVAC
41%
Loosely correlated
-1.38%
BNTX - CVAC
41%
Loosely correlated
+0.55%
IMNM - CVAC
38%
Loosely correlated
-0.23%
ARCT - CVAC
37%
Loosely correlated
-7.49%
More